Human Genome Sciences, Inc. (HGSI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Troll_29 who wrote (59)	2/27/1997 10:30:00 AM
From: David Bogdanoff	of 1127

Amen to full testing. Inadequate testing is a chronic weak point for startup biotech companies trying to get their first product to market. Also, unforseen surprises in the drug development/testig/approval process makes it important to have sufficient , even "excess", cash in the warchest. David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next